|
Establishing Specific Response Criteria for MDS/MPN - Getting Closer to Reality?
|
May 2020
|
Best practice & research. Clinical haematology
|
myelodysplastic syndromes (MDS)
|
|
Cyclosporine Enhances the Sensitivity to Lenalidomide in MDS/AML in Vitro
|
May 2020
|
Experimental Hematology
|
myelodysplastic syndromes (MDS)
|
|
Hematopoietic Cell Transplantation With Cryopreserved Grafts for Severe Aplastic Anemia
|
May 2020
|
Biology of blood and marrow transplantation: journal of the America Society of Blood and Marrow Transplantation
|
aplastic anemia
|
|
Baseline Clinical Characteristics and Disease Burden in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH): Updated Analysis From the International PNH Registry
|
May 2020
|
Annals of Hematology
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Immunosuppression and Growth Factors for Severe Aplastic Anemia: New Data for Old Questions
|
May 2020
|
Haematologica
|
aplastic anemia
|
|
Genetics of Progression From MDS to Secondary Leukemia
|
May 2020
|
Blood
|
myelodysplastic syndromes (MDS)
|
|
Secondary Myelodysplastic Syndrome and Leukemia in Acquired Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria
|
May 2020
|
Blood
|
aplastic anemia, myelodysplastic syndromes (MDS), paroxysmal nocturnal hemoglobinuria (PNH)
|
|
Myelodysplastic Syndromes: Moving Towards Personalized Management
|
May 2020
|
Haematologica
|
myelodysplastic syndromes (MDS)
|
|
Controversies on the Consequences of Iron Overload and Chelation in MDS
|
May 2020
|
HemaSphere
|
myelodysplastic syndromes (MDS)
|
|
How I Diagnose Low-Grade Myelodysplastic Syndromes
|
May 2020
|
American Journal of clinical Pathology
|
myelodysplastic syndromes (MDS)
|
